Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel plus plinabulin vs docetaxel plus placebo in previously treated advanced NSCLC
CTR20150883Phase 3Completed
- Sponsor
- BeyondSpring Inc.
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plinabulin in non-small cell lung cancer (NSCLC), sponsored by BeyondSpring Inc.. Started Aug 2016; status: completed.
02
Drugs
plinabulin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20150883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150883.